Breaking News Instant updates and real-time market news.

AAOI

Applied Optoelectronics

$21.63

0.19 (0.89%)

, FN

Fabrinet

$44.99

0.28 (0.63%)

06:38
10/05/16
10/05
06:38
10/05/16
06:38

Piper recommends exposure to optical component names

Piper Jaffray analyst Troy Jensen raised his estimates for all companies in his optical component coverage saying strength in optical demand will continue. Consensus estimates don't reflect the magnitude and sustainability of 100G cycle, Jensen tells investors in a research note. He recommends investors get exposure to the group. The analyst raised his price target for Applied Optoelectronics (AAOI) to $27 from $24, for Fabrinet (FN) to $53 from $50, for Finisar (FNSR) to $38 from $31, for Lumentum (LITE) to $47 from $38, for NeoPhotonics (NPTN) to $20 from $17 and for Oclaro (OCLR) to $10.50 from $9. Jensen has Overweight ratings on all six names.

AAOI

Applied Optoelectronics

$21.63

0.19 (0.89%)

FN

Fabrinet

$44.99

0.28 (0.63%)

FNSR

Finisar

$29.86

0.42 (1.43%)

LITE

Lumentum

$42.12

0.67 (1.62%)

NPTN

NeoPhotonics

$16.04

-0.08 (-0.50%)

OCLR

Oclaro

$8.79

0.07 (0.80%)

  • 08

    Nov

  • 14

    Nov

  • 15

    Nov

AAOI Applied Optoelectronics
$21.63

0.19 (0.89%)

08/25/16
CHLM
08/25/16
NO CHANGE
Target $23
CHLM
Buy
Applied Optoelectronics price target raised to $23 from $18 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Applied Optoelectronics (AAOI) to $23 from $18 after it announced a third data center customer, which he believes is Facebook (FB). Shannon says the company is the only one he knows of that is shipping 100G Datacom modules to more than one hyperscale cloud operator. Further, he believes that the 100G QSFP28 market will start to inflect by Q4 and Applied Optoelectronics has the largest exposure to this market driver. The analyst reiterates a Buy rating on Applied Optoelectronics' shares.
09/07/16
PIPR
09/07/16
NO CHANGE
Target $24
PIPR
Overweight
Applied Optoelectronics price target raised to $24 from $19 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Applied Optoelectronics to $24 saying the company last night revised September quarter expectations "meaningfully" above consensus. The analyst believes Applied is in a position to see "impressive growth over the next several quarters as demand for 100G optics continues to inflect." He reiterates an Overweight rating on the shares.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $23
ROTH
Buy
Applied Optoelectronics price target raised to $23 from $18.30 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for Applied Optoelectronics to $23 from $18.30 after the company announced that it now expects to report "substantially better" results for the September quarter. The analyst reiterates a Buy rating on the shares.
09/07/16
COWN
09/07/16
NO CHANGE
Target $28
COWN
Outperform
Applied Optoelectronics price target raised to $28 from $21 at Cowen
Cowen analyst Paul Silverstein raised his price target on Applied Optoelectronics to $28 from $21 after the company raised its guidance. The analyst said the company remains one of his top three picks and reiterated his Outperform rating on Applied Optoelectronics shares.
FN Fabrinet
$44.99

0.28 (0.63%)

07/25/16
NEED
07/25/16
NO CHANGE
Target $48
NEED
Buy
Fabrinet price target raised to $48 from $45 at Needham
Needham analyst Alex Henderson raised his price target for Fabrinet (FN) to $48 from $45 and "solidly" recommends buying the stock as he thinks the company can deliver 30% plus growth with a slight bias to improving margins. However, Henderson believes that Fabrinet is unlikely to see the same type of margin leverage or valuation improvements as Lumentum (LITE), NeoPhotonics (NPTN) and Oclaro (OCLR). Needham has a Buy rating on Fabrinet's shares.
08/16/16
PIPR
08/16/16
NO CHANGE
Target $50
PIPR
Overweight
Fabrinet price target raised to $50 from $44 at Piper Jaffray
Piper Jaffray analyst Troy Jensen raised his price target for Fabrinet to $50 saying the company reported another solid quarter with revenues and margins coming in above consensus estimates. The analyst reiterates an Overweight rating on the shares.
08/16/16
NEED
08/16/16
NO CHANGE
Target $54
NEED
Buy
Fabrinet price target raised to $54 from $48 at Needham
Needham analyst Alex Henderson raised his price target for Fabrinet (FN) to $54 from $48 following the company's better than expected quarterly results and "sharp raise" to guidance. The analyst expects further beat and raise quarters with visibility well out into the first half of 2017. Moreover, Henderson believes the news flow reads through to NeoPhotonics (NPTN), Oclaro (OCLR), and Lumentum (LITE). He reiterates a Buy rating on Fabrinet's shares.
08/18/16
NEED
08/18/16
NO CHANGE
NEED
Nokia, Alcatel-Lucent win positive for optical component companies, says Needham
Needham analyst Alex Henderson says that Alcatel-Lucent (ALU)/Nokia (NOK) announcement of a major contract win to build over 30% share of China Mobile's (CHL) 2016-2017 new construction of optical network is also a major positive for optical component companies such as Oclaro (OCLR), NeoPhotonics (NPTN), Fabrinet (FN), Lumentum (LITE), Inphi (IPHI), and Acacia (ACIA). Henderson thinks this is likely the first of three major awards in China, which will likely result in the current sold-out conditions in the coherent optical market to stretch out well into 2017.
FNSR Finisar
$29.86

0.42 (1.43%)

09/09/16
MKMP
09/09/16
UPGRADE
Target $35
MKMP
Buy
Finisar upgraded to Buy from Neutral at MKM Partners
MKM Partners analyst Michael Genovese upgraded Finisar to Buy and raised its price target to $35 from $21. The analyst is "extremely upbeat on the Optical components/module industry," and said Chinese demand for 10G and 100G Optical modules appears it can stay strong for multiple years. Genovese expects Finisar to ship ROADMs into Verizon starting early in the year, and also likely into China starting late in the year and expects gross margins could be "strong-to-solid for at least several more quarters" given strong demand, tight supply, and its leadership in a few key product categories.
09/09/16
CHLM
09/09/16
NO CHANGE
Target $34
CHLM
Buy
Finisar price target raised to $34 from $24 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised Finisar's price target to $34 following the solid Q1 report and guidance, that showed gross margin sequential improvement and upward earnings revision. The analyst has a Buy rating on Finisar shares.
09/09/16
STFL
09/09/16
NO CHANGE
STFL
Finisar price target raised to $33 from $28 at Stifel
Stifel analyst Patrick Newton raised his price target on Finisar after the company reported stronger than expected results. The analyst says that "improved mix" and the company's decision to eliminate its low margin wireless business enabled it to increase its gross margin guidance to 34%, well above his 32% estimate. Newton says that his positive thesis on the company is playing out more quickly than expected, and he keeps a Buy rating on the shares.
09/09/16
09/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chesapeake (CHK) upgraded to Buy from Hold at Wunderlich with analyst Jason Wangler saying the company's assets are performing and its balance sheet is improving. 2. GameStop (GME) upgraded to Buy from Neutral at Hilliard Lyons. 3. Finisar (FNSR) upgraded to Buy from Neutral at MKM Partners with analyst Michael Genovese saying he is "extremely upbeat on the Optical components/module industry," and Chinese demand for 10G and 100G Optical modules appears it can stay strong for multiple years. 4. Randgold (GOLD) upgraded to Buy from Neutral at UBS with the firm citing the recent pullback in the shares and the potential for a dividend raise in 2017. 5. Teekay LNG (TGP) upgraded to Outperform from Market Perform at Wells Fargo analyst Michael Webber saying the discount to net asset value and the company's progress around financing its order book make the valuation "particularly compelling." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LITE Lumentum
$42.12

0.67 (1.62%)

08/10/16
STFL
08/10/16
NO CHANGE
STFL
Lumentum price target raised to $42 from $31 at Stifel
Stifel analyst Patrick Newton raised his price target on Lumentum after the company reported stronger than expected results. The analyst says that the company's investments in new capacity should allow it to "fully capitalize on growth trends," including China strength and the 10G metro rollout, by the end of the year. He notes that the company's margins improved significantly and he keeps a Buy rating on the shares.
08/11/16
MSCO
08/11/16
DOWNGRADE
MSCO
Underweight
Lumentum downgraded to Underweight from Equal Weight at Morgan Stanley
NPTN NeoPhotonics
$16.04

-0.08 (-0.50%)

09/06/16
NEED
09/06/16
NO CHANGE
Target $20
NEED
Strong Buy
Needham remains a buyer of NeoPhotonics ahead of analyst day
Needham analyst Alex Henderson believes NeoPhotonics (NPTN) is "exceptionally well positioned" for strong results over the next 3-4 quarters. The analyst "aggressively recommends" investors Buy NeoPhotonics' shares before the company's analyst day on September 8. Further, Henderson thinks Acacia's (ACIA) over $4B market cap will likely drive them to be acquisitive, and notes that it may seek to reduce costs as a percent of revenues by a potential acquisition of, for example, NeoPhotonics or Oclaro (OCLR). He reiterates a Strong Buy rating and $20 price target on NeoPhotonics' shares.
09/09/16
CHLM
09/09/16
NO CHANGE
Target $22
CHLM
Buy
NeoPhotonics price target raised to $22 from $17 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised NeoPhotonics' price target to $22 from $17 following yesterday's upbeat analyst event. Shannon said the most important takeaway was the 25% CAGR growth outlook over the next three years, which is well above consensus. The analyst has a Buy rating on NeoPhotonics shares.
OCLR Oclaro
$8.79

0.07 (0.80%)

09/01/16
MKMP
09/01/16
NO CHANGE
Target $10
MKMP
Buy
Oclaro price target raised to $10 from $8 at MKM Partners
MKM Partners analsyt Michael Genovese raised Oclaro's price target to $10 following upbeat management meetings with the CEO and CFO. The analyst increased estimates and said demand is still running ahead of supply. Genovese rates Oclaro a Buy and said it remains a top pick.
09/06/16
STFL
09/06/16
NO CHANGE
STFL
Oclaro price target raised to $10 from $7.50 at Stifel
Stifel analyst Patrick Newton expects Oclaro to benefit from strong increases in demand for its 100G product. He thinks that the company's gross margins and CFP2 ACO production can beat expectations. Newton reiterates a Buy rating on the stock.
10/03/16
JEFF
10/03/16
INITIATION
Target $11.25
JEFF
Buy
Oclaro initiated with a Buy at Jefferies
Jefferies analyst James Kisner initiated Oclaro with a Buy and a $11.25 price target. The analyst expects Oclaro to benefit form strong demand strong demand over the next couple of years driven by multiple secular drivers, including Verizon's metro 100G deployment in the US, China's network buildouts, and robust growth within and between data centers at Web 2.0/hyperscale companies.

TODAY'S FREE FLY STORIES

KBR

KBR

$14.05

-1.43 (-9.24%)

18:47
04/28/17
04/28
18:47
04/28/17
18:47
Hot Stocks
KBR issues statement on SFO investigation »

KBR made the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

SMMT

Summit Therapeutics

$11.00

-0.4 (-3.51%)

18:32
04/28/17
04/28
18:32
04/28/17
18:32
Hot Stocks
Summit Therapeutics publishes results from CoDIFy trial online »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKPYY

Takeda Pharmaceutical Co. Ltd.

$24.83

0.85 (3.54%)

18:14
04/28/17
04/28
18:14
04/28/17
18:14
Hot Stocks
Takeda says FDA grants accelerated approval of ALUNBRIG »

Takeda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNBC

First NBC Bank

$2.65

-0.2 (-7.02%)

18:07
04/28/17
04/28
18:07
04/28/17
18:07
Hot Stocks
FDIC named receiver of First NBC Bank »

First NBC Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGBK

Stonegate Bank

$45.90

-0.52 (-1.12%)

17:47
04/28/17
04/28
17:47
04/28/17
17:47
Earnings
Stonegate Bank reports Q1 non-GAAP EPS 56c, consensus 57c »

Reports Q1 NII $25.89M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PROV

Provident Financial

$19.23

-0.03 (-0.16%)

17:45
04/28/17
04/28
17:45
04/28/17
17:45
Hot Stocks
Provident Financial announces extension of stock repurchase plan »

Provident Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

YGE

Yingli Green Energy

$2.66

-0.03 (-1.12%)

17:40
04/28/17
04/28
17:40
04/28/17
17:40
Hot Stocks
Yingli Green Energy files extension for 2016 Form 20-F filing »

Yingli Green Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPC

Edgewell Personal Care

$71.49

-0.14 (-0.20%)

17:40
04/28/17
04/28
17:40
04/28/17
17:40
Hot Stocks
Breaking Hot Stocks news story on Edgewell Personal Care »

Gabelli raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

ORC

Orchid Island Capital

$10.60

-0.33 (-3.02%)

17:35
04/28/17
04/28
17:35
04/28/17
17:35
Syndicate
Breaking Syndicate news story on Orchid Island Capital »

Orchid Island Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    Jun

AEP

American Electric

$67.83

-0.27 (-0.40%)

17:35
04/28/17
04/28
17:35
04/28/17
17:35
Hot Stocks
AEP Generation Resources seeks bids for supply of coal »

AEP Generation Resources,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORC

Orchid Island Capital

$10.60

-0.33 (-3.02%)

17:34
04/28/17
04/28
17:34
04/28/17
17:34
Syndicate
Breaking Syndicate news story on Orchid Island Capital »

Orchid Island Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 13

    Jun

HBHC

Hancock Holding

$46.70

-0.5 (-1.06%)

, FNBC

First NBC Bank

$2.65

-0.2 (-7.02%)

17:34
04/28/17
04/28
17:34
04/28/17
17:34
Hot Stocks
Whitney to acquire branches, assets, liabilities of First NBC from FDIC »

Hancock Holding Company…

HBHC

Hancock Holding

$46.70

-0.5 (-1.06%)

FNBC

First NBC Bank

$2.65

-0.2 (-7.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TSLA

Tesla

$314.07

5.44 (1.76%)

17:31
04/28/17
04/28
17:31
04/28/17
17:31
Periodicals
Tesla aims to hire engineers from Mexico to work at CA plant, Reuters says »

Tesla is aiming to hire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 30

    May

LMT

Lockheed Martin

$269.45

-1.69 (-0.62%)

17:22
04/28/17
04/28
17:22
04/28/17
17:22
Hot Stocks
Lockheed Martin awarded $332.1M government contract »

Lockheed Martin, Orlando,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BA

Boeing

$184.83

1.61 (0.88%)

17:21
04/28/17
04/28
17:21
04/28/17
17:21
Hot Stocks
Boeing awarded $541M government contract modification »

The Boeing Co., Ridley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

WBA

Walgreens Boots Alliance

$86.54

0.65 (0.76%)

, RAD

Rite Aid

$4.00

0.05 (1.27%)

17:20
04/28/17
04/28
17:20
04/28/17
17:20
Periodicals
Walgreens to push regulators over decision on Rite Aid deal, NY Post says »

Walgreens (WBA) will…

WBA

Walgreens Boots Alliance

$86.54

0.65 (0.76%)

RAD

Rite Aid

$4.00

0.05 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$28.99

-0.09 (-0.31%)

17:20
04/28/17
04/28
17:20
04/28/17
17:20
Hot Stocks
General Electric awarded $670.7M government contract »

General Electric, Lynn,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 31

    May

  • 22

    Jun

SIX

Six Flags

$62.61

-0.26 (-0.41%)

17:19
04/28/17
04/28
17:19
04/28/17
17:19
Hot Stocks
Six Flags in agreement to repurchase 5M shares from HP Partners »

Six Flags Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 17

    May

  • 18

    May

LMT

Lockheed Martin

$269.45

-1.69 (-0.62%)

17:18
04/28/17
04/28
17:18
04/28/17
17:18
Hot Stocks
Lockheed Martin awarded $1.38B government contract »

Lockheed Martin Corp.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SBBP

Strongbridge Biopharma

$4.50

0.05 (1.12%)

17:16
04/28/17
04/28
17:16
04/28/17
17:16
Syndicate
Breaking Syndicate news story on Strongbridge Biopharma »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

CYH

Community Health

$8.61

0.18 (2.14%)

17:12
04/28/17
04/28
17:12
04/28/17
17:12
Hot Stocks
Community Health completes divestiture of Anniston, Alabama hospital »

Community Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 06

    Jun

MRUS

Merus

$22.20

-0.14 (-0.63%)

17:07
04/28/17
04/28
17:07
04/28/17
17:07
Earnings
Merus reports Q4 EPS (EUR1.91) vs. (EUR0.77) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

AEZS

Aeterna Zentaris

$3.35

0.3 (9.84%)

17:01
04/28/17
04/28
17:01
04/28/17
17:01
Hot Stocks
Aeterna Zentaris to announces top-line Zoptrex phase 3 results on Monday »

Aeterna Zentaris will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

ANY

Sphere 3D

$0.19

-0.006 (-3.13%)

17:00
04/28/17
04/28
17:00
04/28/17
17:00
Syndicate
Breaking Syndicate news story on Sphere 3D »

Sphere 3D files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

MRUS

Merus

$22.20

-0.14 (-0.63%)

16:56
04/28/17
04/28
16:56
04/28/17
16:56
Hot Stocks
Merus provides anticipated 2017 pipeline milestones »

Merus provided 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.